stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Madrigal Pharmaceuticals IncMDGL
$398.085.67%-23.91

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc stock is traded at $398.08, with a volume of 635,361. It is down -5.67% in the last 24 hours and down -11.49% over the past month. Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Previous Close:
$421.99
Open:
$420.86
24h Volume:
635,361
Relative Volume:
1.13
Market Cap:
$9.25B
Revenue:
$1.13B
Net Income/Loss:
-$309.44M
P/E Ratio:
-
EPS:
-$12.80
Net Cash Flow:
-$275.41M
1W Performance:
-8.07%
1M Performance:
-11.49%
6M Performance:
-23.77%
1Y Performance:
-28.79%
1-Day Range:
$393.30$425.17
1-Week Range:
$393.30$434.48
52-Week Range:
$353.54$615.00

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
Madrigal Pharmaceuticals Inc
Phone
404-380-9263
Address
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, USA
Employee
915
Next Earnings Date
-
Latest SEC Filings
SEC
MDGL's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Madrigal Pharmaceuticals Inc Stock (MDGL) Financials Data

Similar to MDGL